← Back to Clinical Trials
Recruiting NCT07351422

NCT07351422 Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07351422
Status Recruiting
Phase
Sponsor University of Edinburgh
Condition Takayasu Arteritis
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-10-01
Primary Completion 2027-03-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Questionnaire

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-10-01 with a primary completion date of 2027-03-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.

Eligibility Criteria

Inclusion Criteria: For the patient questionnaire: * Age ≥ 18 years * A formal diagnosis of TAK For the physician questionnaire • A physician involved in the management/decision-making for patients diagnosed with TAK Exclusion Criteria: For the patient questionnaire: * Age \< 18 years * Lack of a formal diagnosis of TAK * Patients without mental capacity or willingness to provide informed consent * Not UK based For the physician questionnaire * Not involved in the management/ decision making for patients diagnosed with TAK * Not willing to take part * Not UK based

Contact & Investigator

Central Contact

Alexandra Armstrong

✉ A.Armstrong-9@sms.ed.ac.uk

📞 +447445695898

Frequently Asked Questions

Who can join the NCT07351422 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Takayasu Arteritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07351422 currently recruiting?

Yes, NCT07351422 is actively recruiting participants. Contact the research team at A.Armstrong-9@sms.ed.ac.uk for enrollment information.

Where is the NCT07351422 trial being conducted?

This trial is being conducted at Edinburgh, United Kingdom.

Who is sponsoring the NCT07351422 clinical trial?

NCT07351422 is sponsored by University of Edinburgh. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology